Growth-arrest-dependent expression and phosphorylation of p27kip at serine10 is mediated by the JNK pathway in C6 glioma cells

Molecular and Cellular Neuroscience

Volumn 38, Issue 3, 2008, Pages 301-311

  Mielke, Kirsten ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

c Jun N terminal kinase; Cell cycle; Differentiation; Glioma; Growth arrest; p27kip

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GLIOMA CELL; GROWTH DISORDER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENZYME STABILITY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 10; PHOSPHORYLATION; RATS; RNA, MESSENGER; SERINE;

EID: 45649085244     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.12.007     Document Type: Article

References (31)

1. Boehm M., Yoshimoto T., Crook M.F., Nallamshetty S., True A., Nabel G.J., and Nabel E.G. A growth factor-dependent nuclear kinase phosphorylates p27kip1 and regulates cell cycle progression. EMBO J. 21 (2002) 3390-3401
2. Bost F., Dean N., McKay R., and Mercola D. The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem. 272 (1997) 33422-33429
3. Carrano A.C., Eytan E., Hershko A., and Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1 (1999) 193-199
4. Davis R.J. Signal transduction of the JNK group of MAP kinases. Cell 103 (2000) 239-252
5. Ehrhardt C., Schmolke M., Matzke A., Knoblauch A., Will C., Wixler V., and Ludwig S. Polyethylenimine, a cost-effective transfection reagent. Signal Transduct. 6 (2006) 179-184
6. Hengst L., and Reed S.I. Translational control of p27Kip1 accumulation during the cell cycle. Science 271 (1996) 1861-1864
7. Herdegen T., Mielke K., and Kallunki T. c-Jun and the c-Jun amino-terminal kinases: bipotential components of the neuronal stress response. Neuroscientist 5 (1998) 88-94
8. Ip Y.T., and Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr. Opin. Cell Biol. 10 (1998) 205-219
9. Ishida N., Kitagawa M., Hatakeyama S., and Nakayama K. Phosphorylation at serine 10, a major phosphorylation site of p27kip1, increases its protein stability. J. Biol. Chem. 275 (2000) 25146-25154
10. Jurewicz A., Matysiak M., Tybor K., and Selmaj K. TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3. Brain 126 (2003) 1358-1370
11. Kennedy N.J., and Davis R.J. A role of JNK in tumor development. Cell Cycle 2 (2003) 199-201
12. Kotake Y., Nakayama K., Ishida N., and Nakayama K.I. Role of serine 10 phosphorylation in p27 stabilization revealed by analysis of p27 knock-in mice harboring a serine 10 mutation. J. Biol. Chem. 280 (2005) 1095-1102
13. Kuan C.-Y., Whitmarsh A.J., Yang D.D., Liao G., Schloemer A.J., Dong C., Bao J., Banasiak K.J., Haddad G.G., Flavell R.A., and Rakic R.J. A critical role of neural-specific JNK3 for ischemic apoptosis. PNAS 100 (2003) 15184-15189
14. MacCorkle R.A., and Tan T. Inhibition of JNK2 disrupts anaphase and produces aneuploidy in mammalian cells. J. Biol. Chem. 279 (2004) 40112-40121
15. Mielke K., and Herdegen T. JNK and p38 stress kinases - degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 61 (2000) 45-60
16. Mielke K., and Herdegen T. Fatal shift of signal transduction is an integral part of neuronal differentiation: JNKs realize TNFα-mediated apoptosis in neuronlike, but not naïve, PC12 cells. Mol. Cell. Neurosci. 20 (2002) 211-224
17. Morgan D.O. Principles of CDK regulation. Nature 374 (1995) 131-134
18. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., and Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269 (1995) 682-685
19. Potapova O., Gorospe M., Bost F., Dean N.M., Gaarde W.A., Mercola D., and Holbrook N.J. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J. Biol. Chem. 275 (2000) 24767-24775
20. Rodier G., Montagnoli A., Marcotullio L., Coulombe P., Draetta G.F., Pagano M., and Meloche S. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 20 (2001) 6672-6682
21. Servant M.J., Coulombe P., Turgion B., and Meloche S. Differential regulation of p27(kip1) expression by mitogenic and hypertrophic factors: involvement of transcriptional and posttranscriptional mechanisms. J. Cell Biol. 148 (2000) 543-556
22. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
23. Tsihlias J., Kapusta L., and Slingerland J. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med. 50 (1999) 401-423
24. Tsuiki H., Tnani M., Okamoto I., Kenyon L.C., Emlet D.R., Holgado-Madruga M., Lanham I.S., Joynes C.J., Vo K.T., and Wong A.J. Constitutively active forms of the c-Jun NH2-terminal kinase are expressed in primary glial tumors. Cancer Res. 63 (2003) 250-255
25. Waetzig V., and Herdegen T. A single c-Jun N-terminal kinase isoform (JNK3-p54) is an effector in both neuronal differentiation and cell death. J. Biol. Chem. 278 (2003) 567-572
26. Wu F.Y., Wang S.E., Sanders M.E., Shin I., Rojo F., Baselga J., and Arteaga C.L. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Cancer Res. 66 (2006) 2162-2172
27. Yang D.D., Kuan C.-Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., and Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the JNK3 gene. Nature 289 (1997) 865-870
28. Yao R., Yoshihara M., and Osada H. Specific activation of a c-Jun NH2-terminal kinase isoform and induction of a neurite outgrowth in PC-12 cells by stauroporine. J. Biol. Chem. 272 (1997) 18261-18266
29. Yoshida S., Fukino K., Harada H., Nagai H., Imoto I., Inazawa J., Takahashi H., Teramoto A., and Emi M. The c-Jun NH2-terminal kinase 3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumors. J. Hum. Genet. 46 (2001) 182-187
30. Xu X.S., Vanderziel C., Bennett C.F., and Monia B.P. A role for c-Raf kinase and HA-Ras in cytokine mediated induction of cell adhesion molecules. J. Biol. Chem. 273 (1998) 33230-33238
31. Xu Z., Maroney A.C., Dobrzanski P., Kukekov N.V., and Greene L.A. The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Mol. Cell. Biol. 21 (2001) 4713-4724